Amol Pharmaceuticals Successfully Completes ISO 13485:2016 & GMP Recertification Audit

Amol Pharmaceuticals Pvt. Ltd. has successfully completed its ISO 13485:2016 and GMP Recertification Audit, conducted by SIS Certifications at the company’s facility in the Sitapura Industrial Area, Sanganer, Jaipur.

The recertification audit covered the organisation’s scope for the Design, Development, Manufacturing and Supply of Nasal Wash Kits, with the assessment focused on applicable ISO 13485:2016 and Good Manufacturing Practices (GMP) requirements.

The audit was carried out through a structured, systematic and professional assessment process, with particular emphasis on process effectiveness, implementation, documented practices, team engagement and the organisation’s continued commitment to maintaining its quality management and GMP framework.

Amol Pharmaceuticals appreciated the professionalism, technical approach and constructive engagement demonstrated by the SIS Certifications audit team throughout the assessment. The organisation also acknowledged the value of the audit observations and professional inputs provided to support the continual maintenance and improvement of its quality management system and GMP practices.

Commenting on the audit experience, Akash Pareek, Vice President–Quality, Amol Pharmaceuticals Pvt. Ltd., expressed his appreciation for the professional services delivered by SIS Certifications and conveyed the organisation’s interest in continuing its professional association.

The successful completion of the recertification audit represents another important milestone in Amol Pharmaceuticals’ ongoing commitment to quality, regulatory discipline and robust manufacturing practices. It further demonstrates the organisation’s focus on maintaining effective management systems that support the consistent delivery of healthcare-related products.

A Continued Commitment to Quality

For organisations operating in the healthcare and pharmaceutical-related sectors, maintaining effective quality and GMP systems is essential to ensuring consistency, reliability and confidence across operations. Amol Pharmaceuticals’ successful recertification audit reflects its continued efforts to strengthen processes, sustain compliance and drive continual improvement across its quality and manufacturing framework.